Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response.
about
Biological response to prosthetic debris.Immune modulation as a therapeutic strategy in bone regeneration.Engineered protein coatings to improve the osseointegration of dental and orthopaedic implants.Local delivery of mutant CCL2 protein-reduced orthopaedic implant wear particle-induced osteolysis and inflammation in vivoInflammation, fracture and bone repair.Nanocoating for biomolecule delivery using layer-by-layer self-assembly.Suppression of wear-particle-induced pro-inflammatory cytokine and chemokine production in macrophages via NF-κB decoy oligodeoxynucleotide: a preliminary report.Contribution of human osteoblasts and macrophages to bone matrix degradation and proinflammatory cytokine release after exposure to abrasive endoprosthetic wear particles.NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases.Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants.The effect of local IL-4 delivery or CCL2 blockade on implant fixation and bone structural properties in a mouse model of wear particle induced osteolysis.The Role of the Chemokine System in Tissue Response to Prosthetic By-products Leading to Periprosthetic Osteolysis and Aseptic Loosening.NF-κB decoy oligodeoxynucleotide mitigates wear particle-associated bone loss in the murine continuous infusion model.Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model.Shifts in macrophage phenotype at the biomaterial interface via IL-4 eluting coatings are associated with improved implant integration.Effects of aging upon the host response to implants.Mutant monocyte chemoattractant protein-1 protein (7ND) inhibits osteoclast differentiation and reduces oral squamous carcinoma cell bone invasion.
P2860
Q35188740-95FC0705-16E5-4BC3-B691-77212EFACEA1Q35985907-B9EF9592-0B9D-4B68-888A-ED28C5A21880Q36631888-0BE40B32-B65B-4A1F-A308-609B81B23DBFQ36756957-B665274B-EE6E-490C-B4E8-17A6F0140636Q36803719-34E726A7-F7B0-42FD-8FB9-CA490221B3FAQ36807989-35E869CB-6CA6-4609-8425-CCB2157095F4Q38307200-E3CDA1F6-AA94-45C0-9E89-79FBA2D5C8F1Q38760821-6139AD32-8EB0-4123-A49D-DAE6F4F0FEEEQ39142554-E3DE8AB8-AE6E-4574-AC91-6BD35A3B6D22Q39327060-72BF5B17-195C-4270-967B-9CF7DFEACD5CQ41151771-868E5060-40AE-44F5-B98D-EB290848CB39Q41537137-72C3D906-5331-416E-A2ED-F259CBFE467BQ41789639-3A6255C1-9EBB-468B-A4DD-5A8E669CE0E2Q48912595-875C0BD2-089D-46A5-8146-B6B025CC26BEQ48966773-36D2242B-D426-4433-9A30-51FB054D07D3Q51026288-86305B7A-EBA4-47C1-8149-DB0FB7D972CDQ55004939-B0754FCD-8123-4230-A40F-307B5D38CFC5
P2860
Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mutant MCP-1 protein delivery ...... odulate inflammatory response.
@ast
Mutant MCP-1 protein delivery ...... odulate inflammatory response.
@en
type
label
Mutant MCP-1 protein delivery ...... odulate inflammatory response.
@ast
Mutant MCP-1 protein delivery ...... odulate inflammatory response.
@en
prefLabel
Mutant MCP-1 protein delivery ...... odulate inflammatory response.
@ast
Mutant MCP-1 protein delivery ...... odulate inflammatory response.
@en
P2093
P2860
P1433
P1476
Mutant MCP-1 protein delivery ...... odulate inflammatory response.
@en
P2093
Heather Waters
Jukka Pajarinen
Katherine Barcay
Kensuke Egashira
Michael Keeney
Stuart B Goodman
Xinyi Jiang
Zhenyu Yao
P2860
P304
10287-10295
P356
10.1016/J.BIOMATERIALS.2013.09.028
P577
2013-09-26T00:00:00Z